Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors-Reference-Cited by-同舟云学术

Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors

Published:2023-05-03 Issue:6 Volume:20 Page:2864-2875
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Chang Rui¹,Fu Rongrong¹,Huang Yujiao¹²,Zhang Jibing¹,Feng Changshun¹,Wang Rui¹,Yan Hui¹^ORCID,Li Guangyong¹,Chu Xiaohong¹,Yuan Fengjiao³⁴,Jia Dianlong¹,Li Jun¹^ORCID

Affiliation:

1. Laboratory of Drug Discovery and Design, School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, China

2. School of Life Sciences, Beijing University of Chinese Medicine, Beijing 102488, China

3. Joint Laboratory for Translational Medicine Research, Liaocheng People’s Hospital, Liaocheng 252000, China

4. School of Clinical Medicine, Shandong University, Jinan 250012, China

Funder

China Postdoctoral Science Foundation

Open Project of Shandong Collaborative Innovation Center for Antibody Drugs

Natural Science Foundation of Shandong Province

The Shandong Province Postgraduate Education Quality Improvement Plan

The Youth Innovative Science and Technology Program of Shandong Colleges and University

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.2c01013

Reference35 articles.

1. The TRAIL to cancer therapy: Hindrances and potential solutions

2. Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges

3. TRAIL therapy and prospective developments for cancer treatment

4. Polymeric mechanical amplifiers of immune cytokine-mediated apoptosis

5. Enhancing the antitumor efficacy of a cell-surface death ligand by covalent membrane display

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRIAL-based combination therapies in cancers;International Immunopharmacology;2024-09

2. Targeting the Gut: A Systematic Review of Specific Drug Nanocarriers;Pharmaceutics;2024-03-21

3. Efficient treatment of colon cancer with codelivery of TRAIL and imatinib by liposomes;Pharmaceutical Development and Technology;2024-01-02

4. Material and Design Toolkit for Drug Delivery: State of the Art, Trends, and Challenges;ACS Applied Materials & Interfaces;2023-11-23

5. Recent advancements in nanomedicine based lipid metabolism for tumour immunotherapy;Journal of Drug Targeting;2023-11-23